| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $20.75B | +5.7% |
| Cost of Revenue | $13.87B | +4.3% |
| R&D Expense | $665.0M | +8.0% |
| SG&A Expense | $3.23B | -0.9% |
| Pre-tax Income | $2.91B | +0.5% |
| Income Tax | $445.0M | -40.7% |
| Net Income | $2.46B | +14.8% |
| EPS (Basic) | $6.17 | +14.7% |
| EPS (Diluted) | $6.14 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $294.0M | -1.0% |
| Short-term Investments | $261.0M | -3.7% |
| Accounts Receivable | $4.08B | +23.6% |
| Inventory | $3.43B | +15.5% |
| Current Assets | $8.75B | +16.4% |
| Total Assets | $35.01B | +2.9% |
| Current Liabilities | $6.36B | -11.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $2.53B | +17.1% |
| Capital Expenditures | $598.0M | +4.0% |
| Investing Cash Flow | -$1.20B | +32.0% |
| Financing Cash Flow | -$1.34B | -150.5% |
| Free Cash Flow | $1.94B | +21.9% |
| +15.0% |
| Long-term Debt |
| $8.33B |
| -2.7% |
| Stockholders' Equity | $17.04B | +3.8% |